---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-020997"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2021-08-23T23:59:59+00:00"
generated_at: "2026-06-29T08:18:11.751730+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pure Bioscience appoints Ivan Chen as Board Chair, replacing Tom Lee

## Summary
- Ivan Chen, current non-employee director, appointed Board Chair effective August 19, 2021.
- Tom Lee steps down as Chair but remains President and Chief Executive Officer.
- No other changes to the Board or management.

## SEC filing metadata
- accession: 0001493152-21-020997
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2021-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315221020997/0001493152-21-020997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315221020997/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-020997
- JSON: https://secwatch.observer/filing/0001493152-21-020997.json
- Plain text: https://secwatch.observer/filing/0001493152-21-020997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.